Literature DB >> 22362582

The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.

Marian L Neuhouser1, JoAnn E Manson, Amy Millen, Mary Pettinger, Karen Margolis, Elizabeth T Jacobs, James M Shikany, Mara Vitolins, Lucile Adams-Campbell, Simin Liu, Erin LeBlanc, Karen C Johnson, Jean Wactawski-Wende.   

Abstract

The authors' objective was to discern whether lifestyle or health-related factors were confounders, effect modifiers, or irrelevant with regard to understanding observational associations of serum 25-hydroxyvitamin D (25(OH)D) with colorectal and breast cancer. The authors conducted nested case-control studies of colorectal cancer (310 cases, 310 controls) and breast cancer (1,080 cases, 1,080 controls) in the Women's Health Initiative Calcium and Vitamin D Clinical Trial (1994-2005). Case-control matching factors included age, latitude, race/ethnicity, and blood collection date. Serum 25(OH)D was assayed in baseline fasting blood. Conditional logistic regression was used to estimate odds ratios for each cancer by serum 25(OH)D concentration, comparing the relative effects of successively adding body mass index, physical activity, and other health and lifestyle characteristics particular to each cancer. In models with matching factors only, low (vs. high) serum 25(OH)D was associated with a colorectal cancer odds ratio of 2.72 (95% confidence interval (CI): 1.55, 4.77) and a breast cancer odds ratio of 1.33 (95% CI: 1.02, 1.72). In multivariate-adjusted models for colorectal cancer, the association strengthened (OR = 4.45, 95% CI: 1.96, 10.10). However, in multivariate-adjusted breast cancer models, associations were no longer significant (OR = 1.06, 95% CI: 0.78, 1.43). Adjusting for health and lifestyle characteristics has differential effects depending on the cancer site; when modeling such relations, investigators should take these factors into account.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22362582      PMCID: PMC3324430          DOI: 10.1093/aje/kwr350

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  46 in total

1.  Validating and improving models for projecting the absolute risk of breast cancer.

Authors:  M H Gail; J P Costantino
Journal:  J Natl Cancer Inst       Date:  2001-03-07       Impact factor: 13.506

2.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.

Authors:  J David Curb; Anne McTiernan; Susan R Heckbert; Charles Kooperberg; Janet Stanford; Michael Nevitt; Karen C Johnson; Lori Proulx-Burns; Lisa Pastore; Michael Criqui; Sandra Daugherty
Journal:  Ann Epidemiol       Date:  2003-10       Impact factor: 3.797

3.  Plasma vitamin D metabolites and risk of colorectal cancer in women.

Authors:  Diane Feskanich; Jing Ma; Charles S Fuchs; Gregory J Kirkner; Susan E Hankinson; Bruce W Hollis; Edward L Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

4.  The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro.

Authors:  P Lointier; M J Wargovich; S Saez; B Levin; D M Wildrick; B M Boman
Journal:  Anticancer Res       Date:  1987 Jul-Aug       Impact factor: 2.480

5.  Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States).

Authors:  Marjorie L McCullough; Andrea S Robertson; Carmen Rodriguez; Eric J Jacobs; Ann Chao; Jonas Carolyn; Eugenia E Calle; Walter C Willett; Michael J Thun
Journal:  Cancer Causes Control       Date:  2003-02       Impact factor: 2.506

6.  Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.

Authors:  E A Platz; S E Hankinson; B W Hollis; G A Colditz; D J Hunter; F E Speizer; E Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-10       Impact factor: 4.254

7.  Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells.

Authors:  G Pirianov; K W Colston
Journal:  Steroids       Date:  2001 Mar-May       Impact factor: 2.668

8.  Intake of dairy products, calcium, and vitamin d and risk of breast cancer.

Authors:  Myung-Hee Shin; Michelle D Holmes; Susan E Hankinson; Kana Wu; Graham A Colditz; Walter C Willett
Journal:  J Natl Cancer Inst       Date:  2002-09-04       Impact factor: 13.506

9.  Do sunlight and vitamin D reduce the likelihood of colon cancer?

Authors:  C F Garland; F C Garland
Journal:  Int J Epidemiol       Date:  1980-09       Impact factor: 7.196

10.  Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Authors:  Ulrike Peters; Richard B Hayes; Nilanjan Chatterjee; Wen Shao; Robert E Schoen; Paul Pinsky; Bruce W Hollis; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-04       Impact factor: 4.254

View more
  26 in total

1.  Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.

Authors:  Dan Wang; Omar Israel Vélez de-la-Paz; Jun-Xia Zhai; Dian-Wu Liu
Journal:  Tumour Biol       Date:  2013-06-27

2.  Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies.

Authors:  Jennifer L Kelly; Gilles Salles; Bryan Goldman; Richard I Fisher; Pauline Brice; Oliver Press; Olivier Casasnovas; David G Maloney; Pierre Soubeyran; Lisa Rimsza; Corinne Haioun; Luc Xerri; Michael LeBlanc; Hervé Tilly; Jonathan W Friedberg
Journal:  J Clin Oncol       Date:  2015-03-30       Impact factor: 44.544

Review 3.  Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Authors:  Ruoxu Dou; Kimmie Ng; Edward L Giovannucci; JoAnn E Manson; Zhi Rong Qian; Shuji Ogino
Journal:  Br J Nutr       Date:  2016-05       Impact factor: 3.718

4.  Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.

Authors:  Kathleen Torkko; Cathee Till; Catherine M Tangen; Phyllis J Goodman; Xiaoling Song; Jeannette M Schenk; M Scott Lucia; Ulrike Peters; Adrie van Bokhoven; Ian M Thompson; Marian L Neuhouser
Journal:  Cancer Prev Res (Phila)       Date:  2020-02-26

5.  Single-Nucleotide Polymorphisms in Vitamin D-Related Genes May Modify Vitamin D-Breast Cancer Associations.

Authors:  Katie M O'Brien; Dale P Sandler; H Karimi Kinyamu; Jack A Taylor; Clarice R Weinberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-10-25       Impact factor: 4.254

6.  Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.

Authors:  Marjorie L McCullough; Emilie S Zoltick; Stephanie J Weinstein; Veronika Fedirko; Molin Wang; Nancy R Cook; A Heather Eliassen; Anne Zeleniuch-Jacquotte; Claudia Agnoli; Demetrius Albanes; Matthew J Barnett; Julie E Buring; Peter T Campbell; Tess V Clendenen; Neal D Freedman; Susan M Gapstur; Edward L Giovannucci; Gary G Goodman; Christopher A Haiman; Gloria Y F Ho; Ronald L Horst; Tao Hou; Wen-Yi Huang; Mazda Jenab; Michael E Jones; Corinne E Joshu; Vittorio Krogh; I-Min Lee; Jung Eun Lee; Satu Männistö; Loic Le Marchand; Alison M Mondul; Marian L Neuhouser; Elizabeth A Platz; Mark P Purdue; Elio Riboli; Trude Eid Robsahm; Thomas E Rohan; Shizuka Sasazuki; Minouk J Schoemaker; Sabina Sieri; Meir J Stampfer; Anthony J Swerdlow; Cynthia A Thomson; Steinar Tretli; Schoichiro Tsugane; Giske Ursin; Kala Visvanathan; Kami K White; Kana Wu; Shiaw-Shyuan Yaun; Xuehong Zhang; Walter C Willett; Mitchel H Gail; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  J Natl Cancer Inst       Date:  2019-02-01       Impact factor: 13.506

Review 7.  Function of the vitamin D endocrine system in mammary gland and breast cancer.

Authors:  JoEllen Welsh
Journal:  Mol Cell Endocrinol       Date:  2017-06-01       Impact factor: 4.102

8.  Periodontal Disease and Breast Cancer-Response.

Authors:  Jo L Freudenheim; Amy E Millen; Jean Wactawski-Wende
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05       Impact factor: 4.254

9.  Higher blood 25(OH)D level may reduce the breast cancer risk: evidence from a Chinese population based case-control study and meta-analysis of the observational studies.

Authors:  Peizhan Chen; Mian Li; Xiaoli Gu; Yanling Liu; Xiaoguang Li; Chenglin Li; Yuan Wang; Dong Xie; Fudi Wang; Chen Yu; Jingquan Li; Xinlei Chen; Ruiai Chu; Jianmin Zhu; Zhouluo Ou; Hui Wang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Authors:  Stephanie Scarmo; Yelena Afanasyeva; Per Lenner; Karen L Koenig; Ronald L Horst; Tess V Clendenen; Alan A Arslan; Yu Chen; Göran Hallmans; Eva Lundin; Sabina Rinaldi; Paolo Toniolo; Roy E Shore; Anne Zeleniuch-Jacquotte
Journal:  Breast Cancer Res       Date:  2013-02-26       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.